Skip to main content

Instant FDA drug labels and safety data for clinicians, no login required.

Get alerts when this product posts new revenue milestones.
Desktop Screenshot (similarweb)
Tap to cycle
1/8

Product memo

Targets clinicians at the bedside who need rapid, reliable drug information without friction. It wedges into the market by providing direct FDA API access, emphasizing privacy with no login or data collection. This direct-to-source approach builds trust and utility in critical care scenarios where data accuracy and immediate availability are paramount, bypassing the bloat of traditional medical reference tools.

For who

Clinicians at the bedside

Solves what

Instant access to FDA drug labels, adverse events, and recall history.

  • Direct FDA data access
  • Offline label caching
  • Drug interaction checker
"

In their own words

FDA drug reference.

Built for the bedside.

Search FDA-approved drug labels, adverse events and recall history in seconds. No login, no setup, no noise.

Commercial cues

Pricing snapshot Pricing still unknown

Model

hybrid

Free tier

Yes

Trial

No

No public pricing tiers captured.

Operator context

Team

Indie / lean

Founded

May 2026

HQ

United States

Platform

Mobile

Audience

Developers

Builder Strategy

Strategy Type
Niche Specialist
Stage
Bootstrapped Lean
Effort
Solo Buildable
Core Thesis

Targets clinicians needing bedside drug data, leveraging direct FDA API access and offline capabilities as a core wedge.

Unfair Advantages

  • Exclusive Distribution App Store listing provides direct access to target users

  • Unorthodox Pricing Generous free tier drives adoption, monetizing advanced features via tiered subscriptions

Builder Lesson

Offer a highly functional free tier with core data to drive adoption, then gate advanced clinical tools behind subscriptions.

Full Reasoning

Wins by laser-focusing on a critical clinician need: immediate, reliable drug data at the bedside. The wedge is its direct FDA API access combined with a no-login, privacy-first approach, which is a powerful trust signal in healthcare. The asymmetric bet here is building a mobile-first experience that prioritizes speed and utility over broad, often unused, feature sets. Builders should learn to own a specific workflow pain point and deliver it with extreme focus and trust-building mechanics, rather than trying to be all things to all people.

About LabelMD — FDA Drug Labels Reference Expand

LabelMD is an iOS application designed specifically for clinicians who need immediate, reliable drug information at the point of care. It offers instant access to critical data, including FDA-approved drug labels, adverse event reports, and recall history.

Unlike many traditional medical reference tools, LabelMD prioritizes speed and privacy by offering direct FDA API access without requiring a login or collecting user data. This approach ensures that healthcare professionals can quickly find the information they need, even offline, fostering trust in critical care scenarios.

The app's unique value proposition lies in its ability to strip away complexity, providing a focused tool that helps clinicians make informed decisions efficiently. Its freemium model allows widespread access to essential data, with paid tiers unlocking advanced features like a drug interaction checker and an NDC barcode scanner for enhanced utility.

© 2026 ProvenRadar. Market intelligence for indie builders.